Literature DB >> 31203635

Bacillus coagulans and its applications in medicine.

Y Mu1, Y Cong2.   

Abstract

Bacillus coagulans is a probiotic bacterium that produces spores. Due to its excellent stability, it has been widely used in medicine, food and chemical industry. Recent studies have shown that B. coagulans has therapeutic effects on intestinal diseases, such as acute diarrhoea, irritable bowel syndrome, antibiotic-related diarrhoea, constipation and colitis via modulation of the microbiota composition, host immunity and metabolism. Additionally, toxicological experiments and a large number of clinical observations have showed that B. coagulans is safe and has no effect of mutagenicity, teratogenicity or genotoxicity. This review summarises the latest advances associated with B. coagulans, from its biological features, probable action mechanisms, toxicity, and medical applications.

Entities:  

Keywords:  Bacillus coagulans; medical application

Year:  2019        PMID: 31203635     DOI: 10.3920/BM2019.0016

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  8 in total

Review 1.  Functional Foods, Nutraceuticals and Probiotics: A Focus on Human Health.

Authors:  Morayma Ramírez Damián; Naima G Cortes-Perez; Erika T Quintana; Alicia Ortiz-Moreno; Cynthia Garfias Noguez; Carlos Eugenio Cruceño-Casarrubias; María Elena Sánchez Pardo; Luis G Bermúdez-Humarán
Journal:  Microorganisms       Date:  2022-05-21

2.  Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant].

Authors:  Anil Kumar Gupta; Chiranjit Maity
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

3.  Effects of Probiotics on the Growth Performance, Antioxidant Functions, Immune Responses, and Caecal Microbiota of Broilers Challenged by Lipopolysaccharide.

Authors:  Yang Yu; Qing Li; Xinfu Zeng; Yinglei Xu; Kan Jin; Jinsong Liu; Guangtian Cao
Journal:  Front Vet Sci       Date:  2022-02-21

Review 4.  Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.

Authors:  Tao Zhang; Cunzheng Zhang; Jindong Zhang; Feng Sun; Liping Duan
Journal:  Front Cell Infect Microbiol       Date:  2022-04-01       Impact factor: 6.073

5.  Bacillus coagulans in Combination with Chitooligosaccharides Regulates Gut Microbiota and Ameliorates the DSS-Induced Colitis in Mice.

Authors:  Zhenzhen Liu; Ziyang Jiang; Zhenting Zhang; Tong Liu; Yurong Fan; Tao Liu; Nan Peng
Journal:  Microbiol Spectr       Date:  2022-07-28

Review 6.  Probiotics as Alternatives to Antibiotics for the Prevention and Control of Necrotic Enteritis in Chickens.

Authors:  Raveendra R Kulkarni; Carissa Gaghan; Kaitlin Gorrell; Shayan Sharif; Khaled Taha-Abdelaziz
Journal:  Pathogens       Date:  2022-06-16

7.  Efficacy of Bacillus coagulans BC01 on loperamide hydrochloride-induced constipation model in Kunming mice.

Authors:  Xu Zhou; Yafang Chen; Xin Ma; Yang Yu; Xueping Yu; Xiaoyong Chen; Huayi Suo
Journal:  Front Nutr       Date:  2022-09-21

8.  Draft Genome Sequence of Bacillus safensis RP10, Isolated from Soil in the Atacama Desert, Chile.

Authors:  Erwin Strahsburger; Felipe Zapata; Inti Pedroso; Derie Fuentes; Paz Tapia; Raul Ponce; Michael McClelland; Jorge Valdes
Journal:  Microbiol Resour Announc       Date:  2019-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.